Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Zealand Pharma
Zealand Pharma
Zealand raises $212.5M to advance obesity pipeline
Clinical Trials Arena
Tue, 01/9/24 - 09:37 am
Zealand Pharma
obesity
funding
FDA ends busy year with three drug rejections
BioPharma Dive
Tue, 01/2/24 - 10:13 pm
FDA
Amgen
Zealand Pharma
Merck
Boehringer moves obesity therapy into phase 3
Pharmaphorum
Fri, 10/6/23 - 10:01 am
Boehringer Ingelheim
Zealand Pharma
clinical trials
obesity
survodutide
Spotlight – Nash in 2023 and beyond
EP Vantage
Thu, 08/3/23 - 10:03 am
NASH
Boehringer Ingelheim
Zealand Pharma
Akero Therapeutics
Axcella Health
Eli Lilly
Pfizer
Ionis Pharmaceuticals
Cascade
AstraZeneca
Gilead Sciences
Novo Nordisk
Ascletis Pharma
MediciNova
Boehringer's new data drop shows 19% weight loss for phase 2 obesity prospect
Fierce Biotech
Sun, 06/25/23 - 09:46 pm
Boehringer Ingelheim
obesity
clinical trials
Zealand Pharma
survodutide
Zealand, Boehringer's drug meets main weight-loss goal in mid-stage trial
BioSpace
Wed, 05/10/23 - 10:21 am
Boehringer Ingelheim
Zealand Pharma
obesity
clinical trials
BI 456906
Boehringer signals intent in obesity
EP Vantage
Thu, 03/30/23 - 10:05 am
Boehringer Ingelheim
Zealand Pharma
obesity
clinical trials
BI 456906
Zealand Pharma reports data from Phase III short bowel syndrome trial
Clinical Trials Arena
Mon, 10/3/22 - 10:03 am
Zealand Pharma
clinical trials
glepaglutide
short bowel syndrome
Zealand Pharma, Novo Nordisk Ink Licensing Pact For Diabetes Drug
Yahoo/Benzinga
Wed, 09/7/22 - 10:15 am
Zealand Pharma
Novo Nordisk
Zegalogue
diabetes
hypoglycemia
Key data catalysts for the industry’s small players
EP Vantage
Fri, 07/1/22 - 09:35 am
Intercept Pharma
Akero
NASH
Kymera
atopic dermatitis
Zealand Pharma
short bowel syndrome
Relmada
Verona
Anavex
Assembly Biosciences
Aldeyra
MannKind Acquires Wearable Insulin Device from Zealand Pharma
Medical Devices and Diagnostics Industry
Tue, 05/17/22 - 10:27 pm
MannKind
Zealand Pharma
V-Go
insulin
diabetes
devices
Medtech
Workforce Cuts Abound at Zealand Pharma, Merck and Orchard
BioSpace
Thu, 03/31/22 - 10:43 am
Zealand Pharma
Merck
Orchard Therapeutics
layoffs
After spurning Sanofi for diabetes disappointment, Zealand nets FDA approval in severe hypoglycemia
Endpoints
Wed, 03/24/21 - 10:05 am
Zealand Pharma
Zegalogue
hypogylcemia
diabetes
Sanofi
Zealand acquires a struggling diabetes med-tech in push into US market
Endpoints
Mon, 02/10/20 - 10:20 am
Zealand Pharma
M&A
Valeritas
devices
diabetes
Zealand’s Severe Hypoglycemia Treatment Hits the Mark in Another Phase III Trial
BioSpace
Tue, 05/14/19 - 04:58 pm
Zealand Pharma
hypoglycemia
dasiglucagon
HypoPal
Alexion adds to pipeline with two early-stage R&D deals
BioPharma Dive
Wed, 03/20/19 - 12:25 pm
Alexion Pharmaceuticals
Affibody
Zealand Pharma
ABY-039
R&D
Zealand Pharma blueprints an $86M IPO on Nasdaq as it maneuvers its way into PhIII
Endpoints
Sun, 07/9/17 - 11:33 am
Zealand Pharma
IPO
NASDAQ
dasiglucagon
hypoglycemia
glepaglutide
short bowel syndrome
Sanofi's LixiLan Progresses
Yahoo/Zacks.com
Fri, 01/17/14 - 08:37 am
Sanofi
LixiLan
insulin
Lantus
diabetes
Zealand Pharma
Lyxumia
Zealand Pharma, Eli Lilly sign obesity, diabetes research deal
Reuters
Thu, 08/29/13 - 09:31 am
Eli Lilly
Zealand Pharma
obesity
diabetes
R&D
Zealand Pharma Announces GetGoal Duo 1 and GetGoal-L Phase III Data on Lixisenatide (Lyxumia(R))1 to be Presented at ADA
Yahoo/Global NewsWire
Sun, 06/10/12 - 11:14 am
lixisenatide
Zealand Pharma
Sanofi
type 2 diabetes
diabetes